228 related articles for article (PubMed ID: 32891591)
1. Mucormycosis: An 8-year experience of a tertiary care centre in Saudi Arabia.
Elzein F; Albarrag A; Kalam K; Arafah M; Al-Baadani A; Eltayeb N; Aloteibi F; Alrashed A; Abdullah RA; Alasiri S
J Infect Public Health; 2020 Nov; 13(11):1774-1779. PubMed ID: 32891591
[TBL] [Abstract][Full Text] [Related]
2. Invasive mucormycosis in a tertiary care hospital in the western region of Saudi Arabia: 11-year retrospective chart review from 2009 to 2019.
Almarhabi H; Al-Asmari E; Munshi A; Farahat F; Al-Amri A; Almaghraby HQ; Alharbi M; Althaqafi A
J Infect Public Health; 2022 Dec; 15(12):1466-1471. PubMed ID: 36403403
[TBL] [Abstract][Full Text] [Related]
3. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
Bala K; Chander J; Handa U; Punia RS; Attri AK
Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
[TBL] [Abstract][Full Text] [Related]
4. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
[TBL] [Abstract][Full Text] [Related]
5. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
6. Mucormycosis with cutaneous involvement. A retrospective study of 115 cases at a tertiary care hospital in Mexico.
Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Kassack JJ; Araiza J; González GM
Australas J Dermatol; 2021 May; 62(2):162-167. PubMed ID: 33222179
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous mucormycosis.
Skiada A; Petrikkos G
Skinmed; 2013; 11(3):155-9; quiz 159-60. PubMed ID: 23930354
[TBL] [Abstract][Full Text] [Related]
8. Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India.
Pamidimukkala U; Sudhaharan S; Kancharla A; Vemu L; Challa S; Karanam SD; Chavali P; Prakash H; Ghosh AK; Gupta S; Rudramurthy SM; Chakrabarti A
Med Mycol; 2020 Jun; 58(4):425-433. PubMed ID: 31342074
[TBL] [Abstract][Full Text] [Related]
9. Mucormycosis caused by Apophysomyces species: An experience from a tertiary care hospital in Western India and systematic review of global cases.
Samaddar A; Shrimali T; Sharma A
Mycoses; 2023 Mar; 66(3):181-195. PubMed ID: 36227645
[TBL] [Abstract][Full Text] [Related]
10. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
11. Clinical characteristics and outcome of mucormycosis: A multi-center retrospective analysis in Saudi Arabia over 11 years.
Abanamy R; Alsaud A; Alabdulali R; Alsobaie M; Alalwan B; Aljohani S; Alshieban S; Turkistani H; Almohaizeie A; Bosaeed M; AlRabiah F
IJID Reg; 2022 Sep; 4():152-156. PubMed ID: 35941863
[TBL] [Abstract][Full Text] [Related]
12. Mucormycosis at a tertiary care centre in Gujarat, India.
Patel AK; Patel KK; Patel K; Gohel S; Chakrabarti A
Mycoses; 2017 Jun; 60(6):407-411. PubMed ID: 28276102
[TBL] [Abstract][Full Text] [Related]
13. Mucormycosis-A clinicoepidemiological review of cases over 10 years.
Manesh A; Rupali P; Sullivan MO; Mohanraj P; Rupa V; George B; Michael JS
Mycoses; 2019 Apr; 62(4):391-398. PubMed ID: 30685896
[TBL] [Abstract][Full Text] [Related]
14. Rhino-orbito-cerebral mucormycosis: five cases.
Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
[TBL] [Abstract][Full Text] [Related]
15. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India.
Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A
Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus as the major risk factor for mucormycosis in Mexico: Epidemiology, diagnosis, and outcomes of reported cases.
Corzo-León DE; Chora-Hernández LD; Rodríguez-Zulueta AP; Walsh TJ
Med Mycol; 2018 Jan; 56(1):29-43. PubMed ID: 28431008
[TBL] [Abstract][Full Text] [Related]
17. Abdominal tuberculosis in a tertiary care centre in Saudi Arabia.
Elzein F; Kharraz R; Boudal A; Mohamed H; Mursi M; Kuriry H; Albarrak A; AlSherbeeni N
Indian J Tuberc; 2021 Apr; 68(2):236-241. PubMed ID: 33845958
[TBL] [Abstract][Full Text] [Related]
18. Nasal Mucormycosis: Our experience with 24 cases.
Bakshi SS; Das S; Ramesh S; Gopalakrishnan S
Otolaryngol Pol; 2020 Feb; 74(4):37-40. PubMed ID: 32636347
[TBL] [Abstract][Full Text] [Related]
19. Mucormycosis in hematologic patients.
Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A;
Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897
[TBL] [Abstract][Full Text] [Related]
20. Rhino-orbito-cerebral mucormycosis, a retrospective study of 7 cases.
Santos Gorjón P; Blanco Pérez P; Batuecas Caletrío A; Muñoz Herrera AM; Sánchez González F; de la Fuente Cañibano R
Acta Otorrinolaringol Esp; 2010; 61(1):48-53. PubMed ID: 20004878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
